HCA Healthcare, Inc.
HCA Healthcare operates hospitals and other health care facilities that provide inpatient, outpatient and ancillary services to patients in the communities they serve. Its facilities include general acute care, behavioral and rehabilitation hospitals; ambulatory surgery and endoscopy centers; emergency and urgent care facilities; walk-in clinics; diagnostic and imaging centers; physician practices; home health agencies; hospices; and rehabilitation and physical therapy centers. At December 31, 2025, HCA Healthcare operated 190 hospitals, 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers in 19 states and England. HCA Healthcare earns payments for patient services from Medicare, Medicaid, managed care plans, private insurers and patients. Certain affiliates also provide management services to its health care facilities, including accounting, information technology, purchasing, human resources and clinical systems support. HCA Healthcare’s principal executive offices are in Nashville, Tennessee.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
HCA Florida Pasadena Hospital will stop inpatient care by the end of 2026, keeping its ER open. Patients will be transferred to HCA Florida St. Petersburg Hospital. The change follows a review of community needs and hurricane impacts, according to HCA Healthcare.
Rossitto Erica (SVP & Chief Nurse Executive) sold 3,500 shares of HCA Healthcare, Inc. (HCA) at $505.81 ($1.77M total) on 2026-11-10.
HCA Healthcare's EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares at $494.65 each, totaling $593,582. He now directly owns 1,443 shares and indirectly holds 6,951 shares through a trust, per an SEC Form 4 filing.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning HCA (HCA Healthcare, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent HCA coverage spans insider activity, market movers and corporate actions.
In the last 30 days, HCA insiders filed 10 SEC Form 4 transactions — no purchases and 10 sales ($18.3M). The most active reporter was Foster Jon M, EVP and COO, with 8 filings.
Reorganization of a regional hospital within HCA's network.
Insider sale may signal personal liquidity need or lack of confidence, potentially pressuring the stock.
Potential modest selling pressure as a senior executive reduces stake.
Insider sale may signal personal liquidity need or lack of confidence, creating modest downside pressure.
Significant insider sell by a top executive may signal concerns about near-term valuation.
AlphAI scores every news story that mentions HCA with an AI model for sentiment and relevance, and aggregates insider trades from HCA Healthcare, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
HCA Florida Pasadena Hospital will stop inpatient care by the end of 2026, keeping its ER open. Patients will be transferred to HCA Florida St. Petersburg Hospital. The change follows a review of community needs and hurricane impacts, according to HCA Healthcare.
Rossitto Erica (SVP & Chief Nurse Executive) sold 3,500 shares of HCA Healthcare, Inc. (HCA) at $505.81 ($1.77M total) on 2026-11-10.
HCA Healthcare's EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares at $494.65 each, totaling $593,582. He now directly owns 1,443 shares and indirectly holds 6,951 shares through a trust, per an SEC Form 4 filing.
Schlosser Michael J (EVP and Chief Clinical Officer) sold 1,200 shares of HCA Healthcare, Inc. (HCA) at $494.65 ($0.59M total) on 2026-11-04.
Foster Jon M (EVP and COO) sold 31,713 shares of HCA Healthcare, Inc. (HCA) at an average of $500.98 ($491.98–$514.07, $15.89M total) across 8 trades over 2026-11-04 to 2026-11-06.
HCA Healthcare, Inc. (HCA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Issuance of $6,500,000,000 aggregate principal amount of senior notes Overview On November 5, 2026, HCA Inc. (the “ Issuer ”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “ Parent Guarantor ”), completed the
HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.
US hospital operators like HCA, Tenet, and UHS face revenue pressure from rising uninsured patients and reduced government aid. ACA subsidy expiration in 2026 led to premium spikes, causing 3M to drop coverage. HCA estimates a $1.2B income reduction in 2026, with Medicaid cuts expected to further impact profits in 2027 and 2028.
Shares of GoodRx, Evolent Health, UFP Technologies, Centene, and HCA Healthcare surged after Democrats regained majorities in Congress, easing drug pricing policy concerns. Analysts expect the biopharmaceutical sector to benefit from reduced regulatory uncertainty. UFP Technologies, up 21.5%, has seen significant volatility and strong performance, including a 51.1% year-to-date gain.
U.S. election results drove sector-specific stock movements. Clean energy and healthcare stocks rose, while defense, data center, and some tech stocks fell. Key movers include NextEra Energy (+4%), Molina Healthcare (+8%), Lockheed Martin (-7%), CoreWeave (-9%), and Apple (+6%).
